The Real-Time Clinical Trial Network
Revolutionize your clinical trials with Ryght AI. Our secure, AI-powered platform streamlines operations and shatters traditional timelines.
Ryght AI has created an "AI digital twin" of every clinical trial site in the world, matching any trial protocol to the very best sites in any geography, predicting then selecting which sites will succeed. Site identification, feasibility, selection and activation are now slick, automatic and fast.

For Sponsors
Whether it’s to get funding for your study or to get to work with your CRO and start enrolling, our generative AI platform and powerful, global site network can help you identify, select and activate the best sites with the least competition and just start enrolling - all faster than current methods.

For Research Sites
Your lifeblood is new trials, but you are drowning in data requests. Why can't you find trials that just work for you? Why can't you match patients without expensive software integrations?
Now you can. Join the Ryght Research Network. Get the tech for free and let us bring you sponsored trials. No EMR integrations and no PHI required. It's that easy.
Global Site Network
Ryght has built an AI digital twin of every clinical trial site in the world, dynamically updated with AI Agents, allowing you to use our AI to find the best sites for any protocol.
Sites themselves like USC Keck School of Medicine, University of Kansas, West Virginia University, West Clinic, Emory University and many others also use the Ryght Research Platform.
We are deploying our Generative- and Agentic- AI platform and applications to a global network of research sites, then providing access, activation and efficiency to biotech, pharma and CRO partners worldwide.
In a fully AI connected world, friction can disappear, drugs can be approved, and lives can be saved.

Trusted by healthcare and clinical
research companies worldwide
referrals, the Ryght Research Network will allow
us to focus more on advancing patient
care and less on administrative burden while
running the trials that are most likely to succeed."
M.D, Ph.D., Associate Dean of Clinical Research
Keck School of Medicine of the University of Southern California
clinical trials from site selection to activation
and enrollment, ultimately speeding up time to
market for our biopharma clients.”
Executive Vice President and Global Head of Clinical Research
QPS
Interim Director of the Institute for Photonics and Advanced Sensing (IPAS)
Adelaide University